Israel’s BiolineRX has announced positive results for the Phase IIa clinical trial of BL-7040, an oral treatment for inflammatory bowel disease (IBD). Ulcerative colitis and Crohn’s disease affect as many as 1.4 million individuals in the US alone.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000836889&fid=1725